West Pharmaceutical Services Inc

WST: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
!B&LOCK|?RwLOCK|rf!&PBM

West Pharmaceutical Earnings: Recovery Underway, Full-Year Guidance Raised Again

West Pharmaceutical reported organic revenue growth of 6.8% and adjusted diluted earnings per share growth of 21%. It revised its full-year guidance for revenue and adjusted EPS upward again by 3% and 8%, respectively, based on the midpoint of its ranges.

Sponsor Center